World / Science & Health Feb 7, 2021
Oxford-AstraZeneca COVID-19 shot less effective against South African variant, study says
British drugmaker AstraZeneca said on Saturday its vaccine developed with Oxford University appeared to offer only limited protection against mild disease caused by the South African variant of COVID-19, based on early data from a trial. The study from South Africa's University of the Witwatersrand ...
